SGLT2 inhibitors are oral medications that help lower blood sugar in individuals with type 2 diabetes by inhibiting glucose reabsorption within the kidneys, which causes the body to excrete more sugar in the urine [54]. Here, SLC5A2 is linked to type 2 diabetes mellitus.